Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNTB Connect Biopharma > Key Indicators
CNTB Connect Biopharma
0.717
-0.040-5.28%
Post Mkt Price
0.7170.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30
Financial Ratios
Efficiency Ratios TTM
ROIC
44.84% -43.595% -- -366.902% -- -366.902% -- -79.031%
ROE
44.85% -43.599% -- -367.661% -- -367.661% -- -79.059%
ROA
46.08% -40.846% 16.88% -88.884% 16.88% -88.884% -- -75.745%
Efficiency Ratios
Profitability Ratios TTM
Financial Health Ratios
Long-Term Debt to Equity Ratio
580.95% 0.157% -- 0.009% -- 0.009% -- 0.023%
Total Assets to Common Equity
5.57% 110.189% -- 106.903% -- 106.903% -- 104.375%
Debt to Asset Ratio
400.00% 0.264% -- 0.046% -- 0.046% -- 0.053%
Current Ratio
-58.63% 9.5772 -45.00% 15.2979 -45.00% 15.2979 -- 23.1495
Quick Ratio
-58.64% 9.253 -44.74% 14.9042 -44.74% 14.9042 -- 22.3742
GrowthRatios
Growth Ratios
Currency Unit
CNYCNYCNYCNY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
CEO: Dr. Zheng Wei, PhD
Market: NASDAQ
Listing Date: 03/19/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist